CTHRC1 and non-small cell lung carcinoma: In our previous studies, we have found that CTHRC1 promotes non-small cell lung cancer (NSCLC) cell aggressiveness by targeting Wnt/β-catenin pathway, and may serve as a novel biomarker for NSCLC patients [7].